Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Product Collaboration

29 May 2007 07:00

Embargoed Release: 07:00hrs Tuesday 29th May 2007

Nanoscience Inc Toumaz Technology Signs LOI with Healthe To Collaborate on Sensium¢â€ž¢ Solutions for Sports Medicine Agreement With Leading Health and Wellness Group To Develop Sensium¢â€ž¢-Based Applications For Elite Athlete Training and Sport Optimisation

Nanoscience Inc, the specialist niche investor in emerging technologies with strong commercial propositions from within the growing nanotechnology sector, is pleased to announce that its wholly owned subsidiary, Toumaz Technology Limited (`Toumaz') has signed a Letter of Intent (`LOI') with health and wellness group Healthe International Pte Ltd to jointly develop solutions for sports medicine and rehabilitation therapy applications.

The agreement marks the start of a collaboration to trial solutions based on Sensium¢â€ž¢ enabled, ultra small, body-worn, wireless monitors and Healthe's database for elite athletes, Healthe Sport. Toumaz's Sensium sensor interface and transceiver platform enables intelligent, ultra-low power wireless monitoring of multiple vital signs - including ECG heart rate, body temperature, respiration and activity level - in real-time, via standard PDAs, cellphones, laptops and PCs.

Ben Thynne, Managing Director of Healthe International, commented:

"The signing of this LOI is the first step in a very exciting collaboration between our two companies. The potential for Toumaz's Sensium technology in the sports medicine market is immense, and we look forward to exploring opportunities to combine the strengths of our offerings and delivering a new wave of sports monitoring applications fit for the world's top athletes."

Keith Errey, Toumaz Co-Founder and COO, added:

"Healthe is an internationally recognised leader in the field of sports healthcare management, and we are delighted to be announcing the start of our commercial relationship," "We see huge opportunities for a combined Sensium and Healthe Sports solution to have a positive impact in areas such as training, sport optimisation and post-operative fitness, and we look forward to working together to bring these solutions to market."

-ends - Further information:Richard Rose Nanoscience 07836 250 474 Andrew Tan Hansard Group 020 7245 1100 www.hansardgroup.co.uk

About Toumaz Technology (www.toumaz.com)

Toumaz Technology Limited is the leading provider of ultra-low power wireless infrastructure for body monitoring solutions.

Toumaz's ultra low-power smart sensor interface and transceiver platform - the Sensium¢â€ž¢ - enables non-intrusive, real-time wireless monitoring of multiple vital signs for a wide range of healthcare and lifestyle management applications. Based on Toumaz's patented ultra-low power Advanced Mixed Signal (AMx)¢â€ž¢ technology, the Sensium provides the enabling technology to connect the mobile individual to healthcare providers - simply, affordably and unobtrusively.

For healthcare professionals, this transforms the possibilities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible, personalised healthcare, as well as better therapeutic outcomes.

About Healthe (www.healthe.com)

Healthe is an international health and wellness organisation with operations in Singapore and Australia. It was formed in 2002 with a vision to provide an affordable and easy way for Australians to better manage and improve their health and wellness.

Headquartered in Singapore, Healthe Group is an international organisation that provides a wide range of health and wellness solutions, from the largest privately-owned private hospital network in Australia, to state-of-the-art sports performance database systems, corporate health and wellness programmes and individual personal health records. Health Sport, the company's specialised sports healthcare and research system, is designed to help accredited doctors and sports physicians share athlete medical records and clinical data, and manage the condition of elite sportsmen and women. The system, which is based on Oracle's Healthcare Transaction Base (HTB), is currently being used by the Australian Olympic Team and the company is working closely with other elite sporting organisations to implement the system.

Through a wide range of services and solutions, Healthe has the ability to impact on the lives of every person within our community in a positive way.

The Healthe Group comprises

Healthe Me - a health and wellness program that offers a unique combination of benefits and services aimed at improving its members' overall health and wellness, with an online Personal Health Record at the core. Members also enjoy discounts and offers from our reward partners.

Healthe Care -the largest privately-owned private hospital network in Australia, with over 1,500 staff, 1,000 accredited medical practitioners, close to 1,000 beds and the latest in medical technology.

Healthe Work - a Rehabilitation and Occupational Health Consultancy and Workplace Health and Wellness Programs

Healthe Sport - a specialised healthcare and research system that assists accredited doctors and sports physicians to keep world class, elite athletes at the top of their game.

Healthe Solutions - development and delivery of a range of common `Shared Services' functions and next generation practical hospital technology services hosted on a Private Network

Healthe is a major sponsor and product provider to the Australian Olympic Committee.

NANOSCIENCE INC
Date   Source Headline
14th Jun 20197:00 amRNSInvestment in Frontier Smart Technologies Grp Ltd
6th Jun 20195:43 pmRNSHolding(s) in Company
6th Jun 20193:30 pmRNSInvestment in Frontier Smart Technologies Grp Ltd
30th May 20197:00 amRNSFormal Chairman Appointment
29th May 20191:02 pmRNSHolding(s) in Company
29th May 20197:00 amRNSHolding(s) in Company
21st May 20197:00 amRNSHolding(s) in Company
20th May 20199:00 amRNSPrice Monitoring Extension
20th May 20197:00 amRNSTermination of Discussions and Holding in Company
17th May 201912:01 pmRNSHolding(s) in Company
14th May 201912:07 pmRNSResult of Annual General Meeting
9th May 20194:40 pmRNSSecond Price Monitoring Extn
9th May 20194:35 pmRNSPrice Monitoring Extension
9th May 20197:00 amRNSTrading Update
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
20th Mar 20197:00 amRNSFinal Results
7th Mar 20197:00 amRNSBlock listing Interim Review
6th Mar 20197:00 amRNSNotice of Results
28th Feb 20197:00 amRNSFrontier extends focus into Smart Home IoT
17th Jan 20197:00 amRNSTrading Update and Notice of Results
11th Jan 201911:36 amRNSNotification of Major Holdings
30th Nov 20185:19 pmRNSNotification of major holdings
15th Nov 20187:00 amRNSTotal Voting Rights
28th Sep 20183:36 pmRNSBlock Listing Update
18th Sep 20187:00 amRNSHalf-Year Results
16th Aug 20187:00 amRNSTotal Voting Rights
13th Aug 20187:00 amRNSNotice of Results
26th Jul 20187:00 amRNSTrading Update
16th Jul 20187:00 amRNSTotal Voting Rights
9th Jul 20187:00 amRNSBoard Appointment
12th Jun 20184:27 pmRNSTotal Voting Rights
23rd May 201811:05 amRNSSecond Price Monitoring Extn
23rd May 201811:00 amRNSPrice Monitoring Extension
23rd May 20187:00 amRNSTrading Update
8th May 20185:49 pmRNSTotal Voting Rights
24th Apr 201811:58 amRNSResult of Annual General Meeting
29th Mar 20187:00 amRNSBlock Listing Update and TVR
19th Mar 20184:10 pmRNSPosting of Annual Report and Notice of AGM
8th Mar 20187:00 amRNSBoard Changes
8th Mar 20187:00 amRNSFinal Results
20th Feb 20187:00 amRNSNotice of Results
5th Feb 20182:21 pmRNSNotification of major holdings
25th Jan 20187:00 amRNSTrading Update
2nd Jan 20187:00 amRNSNotification of Major Holdings
29th Nov 201712:40 pmRNSDirector/PDMR Shareholding
29th Nov 201712:40 pmRNSTotal Voting Rights
13th Nov 20177:00 amRNSSmart Audio technology contract win
6th Oct 201712:58 pmRNSTotal Voting Rights
28th Sep 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.